Furthermore, we have previously shown that lung cancer CD133+ cells, which are spared by cisplatin treatment in xenografted lung cancer models, are enriched in ABC transporters, including MRP1 and MRP4 [15]. This evidence concerns the gene ABCC1 and lung cancer.